On Wednesday, the health authorities designated monkeypox as a second-degree legal infectious disease out of a four-tier system, as the disease is spreading fast around the globe.Currently, 22 diseases, including Covid-19, tuberculosis, and chickenpox, are grouped as the second-level contagious dise
Starting Wednesday, all international arrivals will not have to isolate themselves for a week whether they received Covid-19 vaccines or not and whether they are Koreans or foreigners.According to officials at the Central Disease Control Headquarters, the lifting of mandatory seven-day self-quaranti
JW Bioscience said Wednesday that it launched a 125-gram ultra-lightweight, portable pneumatometer called “Chestmate” and will soon begin marketting it .Chestmate is a portable device to measure lung capacity equipped with an LCD touch screen, which diagnoses lung function of patients with respirato
Korea AI Center for Drug Discovery and Development (KAICD) said Wednesday that it would recruit expert instructors to develop and teach artificial intelligence (AI) to facilitate drug discovery and practical cooperative research.As an affiliated organization of the Korea Pharmaceutical and Bio-Pharm
Researchers at Seoul National University Bundang Hospital (SNUBH) have found that when they perform “vocal cord injections” to improve patients’ voices by correcting their vocal cords, using a light-guided method is easier and more effective.According to the research team, led by Professor Cha Won-j
Developers of digital therapeutics (DTx) need to embrace regulation as a “necessary evil” and work with clinicians from the beginning of development to pass the regulatory procedure, said an expert who developed FDA-authorized DTx.Jessica Lake, Chief Science Officer (CSO) of Limbix, spoke on dealing
CHICAGO, Ill. – The use of Yuhan Corp.’s anticancer drug Leclaza (lazertinib) in combination with Janssen’s Rybrevant (amivantamab), a bispecific antibody targeting EGFR and MET, drew much attention from international oncologists.At the annual meeting of the American Society of Clinical Oncology in
Johnson & Johnson Innovation and Janssen Korea launched the sixth “Seoul Innovation QuickFire Challenge: Scientific Advancements of Tomorrow” in collaboration with the Seoul Metropolitan Government (SMG) and the Korea Health Industry Development Institute (KHIDI).J&J’s QuickFire Challenge aims to ad
CHICAGO, Ill. – A breast cancer study outcome was so impressive that it received a standing ovation at the American Society of Clinical Oncology (ASCO 2022), the world’s largest meeting in oncology being held in Chicago.The standing ovation went to researchers of phase 3 DESTINY-Breast04 trial of En
The number of patients registered for phase 3 clinical trials of GNT Pharma’s stroke treatment, Nelonemdaz, has exceeded 100, raising expectations for completing all related trials in 2023 as scheduled, the company said Tuesday.Nelonemdaz is the first drug candidate worldwide that received approval
Macrogen, a precision medical biotechnology business, celebrated its 25th anniversary last Friday, unveiling its plan to open the “Macrogen 2.0 era” through high-speed growth and leaping to the digital healthcare business.To this end, Macrogen said it would focus on diversifying its business portfol
For the proposed Infectious Disease Central Hospital (CIDH) to serve as a control tower in a pandemic crisis, an expert said it needs to invest intensively into “software” to strengthen internal capacity, including high-quality staffing.In 2017, the Ministry of Health and Welfare concluded that it i
Korea’s new Covid-19 cases showed a decline for the 11th consecutive week in the first week of June, with teens and 20-somethings showing the highest incidence, health officials said Tuesday.In contrast, both infection rate and share fell among the high-risk group of adults 60 and older as they bega
Amgen Korea and Jeil Pharmaceutical said they signed an agreement to jointly sell Repatha (evolucumab), lipid-lowering drugs for atherosclerotic cardiovascular disease (ASCVD) and hypercholesterolemia starting in June.Under the agreement, Amgen Korea and Jeil Pharmaceutical will conduct Repatha sale
CHICAGO, Ill. – Lilly’s VEGRF2 inhibitor Cyramza (ramucirumab) in combination with Keytruda (pembrolizumab) proved a survival benefit, compared with the existing chemotherapy-based standard of care, in patients with non-small cell lung cancer (NSCLC) whose disease progressed after the first-line imm
CHICAGO, Ill. – Pfizer’s first CDK4/6 inhibitor Ibrance (palbociclib), failed to extend overall survival (OS) in the first breast cancer treatment in the phase 3 PALOMA-2 study.However, the PALOMA-2 study was not designed to check OS data, and it did not include some survival data of patients during
Theragen Bio, a genetic analysis service and AI-based drug development company, said Tuesday that it would begin mass-producing pilot chips of 'Korean Chip 2.0' developed by the Korea Disease Control and Prevention Agency (KDCA).The National Institute of Health under the KDCA will conduct the 'Korea
Korea, designated by the WHO as a global biopharma manufacturing training hub, will start providing education on vaccine manufacturing for workers in the Asia-Pacific region.The Korean government and the Asia Development Bank (ADB) will jointly push for the training project.Korean National Institute
COPENHAGEN – With the 2022 European Alliance of Associations for Rheumatology (EULAR) Congress holding an in-person conference for the first time in two years, Korean professors also had the chance to show off their recent research in the field.Notably, Professor Jung Jae-hyun of the Department of R
COPENHAGEN – Bristol Myers Squibb’s deucravacitinib, a lupus treatment candidate, drew keen attention from global rheumatologists as the company unveiled the phase 2 study at the 2022 European Alliance of Associations for Rheumatology (EULAR) Congress Saturday.The phase 2 PAISLEY study evaluated deu